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Stimulated renal tubular epithelial cells induce anergy in CD4 T cells.
Renal tubular epithelial cells (TEC) can express MHC class II mole-
cules in Vitro and in vivo. Their ability to also secrete cytokines and
express adhesion molecules suggests a possible immune accessory role
for TEC. We have previously documented that TEC process and
present antigen to T cell hybridomas. However, engagement of the T
cell receptor alone is sufficient to induce IL-2 secretion by T cell
hybndomas. We now report that presentation of antigen by TEC to a
CD4 T cell clone results in functional inactivation of the T cells.
Despite antigen-specific anergy, these T cells are viable and proliferate
in response to IL-2. Furthermore, allogeneic antigen presenting cells
were unable to restore the T cell proliferative response, suggesting that
the mechanism(s) was not entirely costimulator-dependent.
Renal tubular epithelial cells (TEC) comprise the majority of
the kidney cortex. The primary physiologic function of TEC is
to maintain salt and water homeostasis. However, recent evi-
dence suggests that these cells may have an immune accessory
role. Notably TEC can be induced to express major histocom-
patibility complex class II (Ia) products during allograft rejec-
tion, autoimmune and ischemic renal injury, and graft versus
host disease [1—5]. Furthermore, we and others established that
in pathologic situations, TEC express the accessory molecules
intercellular adhesion molecule-i (ICAM-l) [6, 7] and vascular
cell adhesion molecule-i (VCAM-1) [8], and produce cytokines,
including tumor necrosis factor a [9], interleukin-8 [101, inter-
leukin-6 (unpublished observations), and transforming growth
factor /3 [11].
The role of Ia on parenchymal cells has been the subject of
much investigation. It has been proposed that "aberrant"
expression of MHC class II molecules can result in the presen-
tation of self antigens to T cells, with the subsequent develop-
ment of organ-specific autoimmune disease [12, 13]. However,
using a transgenic kidney transplant model, we have recently
shown that Ia expression by TEC alone is insufficient to induce
immune renal injury (Note added in proof). An important
function of Ia-positive hematopoietic cells is that of antigen
presentation. Dendritic cells, B lymphocytes and macrophages
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process and present exogenous antigen to CD4 T cells. T
helper (Th) cells appear to require two signals in order to
become activated. The first signal is engagement of the I cell
receptor by the peptide-MHC complex. Signal 2, also referred
to as the costimulatory signal, can be provided by certain
cytokines and adhesion molecules [14]. Jenkins and Schwartz
have shown that TCR engagement by cells incapable of provid-
ing a costimulatory signal results in a state of antigen-specific
unresponsiveness known as anergy [15, 16]. Th cells rendered
anergic fail to respond to antigen-presenting cells expressing
signals 1 and 2, but remain viable, proliferating in response to
IL-2.
To further evaluate the ability of TEC to stimulate T cells, we
investigated the interaction between T cells and TEC in an in
vitro system. We now report that although TEC stimulate IL-2
production by antigen-specific, MHC-restricted T cell hybrido-
mas, they induce a state of anergy in CD4 T cell clones. The
induction of anergy by TEC appears to be independent of
costimulation. Although TEC express many of the molecules
associated with the induction of immune responses, our results
indicate that under certain conditions TEC may down-regulate
autoimmune responses within the kidney.
Methods
Mice
C3H/FeJ (H2k) and BALB/c (H-2") mice were obtained from
The Jackson Laboratory (Bar Harbor, Maine, USA) and main-
tained in our animal facility on standard lab chow. Mice were
used between 6 and 12 weeks of age.
T cell clones and hybrids
A.E7 is a pigeon cytochrome c-specific, IEkrestricted Thi
clone [17]. A2.A2 is a subclone of the T cell hybridoma A2.2B2
which recognizes hen egg lysozyme in the context of I-A' [18].
A.E7 and A2.A2 were provided by Drs. Abul Abbas (Harvard
Medical School, Boston, Massachusetts, USA) and Laurie
Glimcher (Harvard School of Public Health, Boston, Massa-
chusetts, USA), respectively.
TEC clone
CS3. 1 is a renal tubular epithelial cell clone derived from
C3H/FeJ mice. The method of isolation has been previously
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described [19]. Briefly, TEC were prepared by collagenase
dispersion and sequential sieving of renal cortices. Cells were
subcloned by the limiting dilution technique after transforma-
tion with origin-defective SV4O DNA. Characterization of the
tubular nature of these cells was as follows. CS3. 1 cells display
epithelial morphology and express the brush border enzyme
alkaline phosphatase. They stain positively for cytokeratin and
vimentin. They express ICAM-l constitutively, and IFN-y
up-regulates ICAM-1 and induces Ia expression.
Reagents
Tissue culture media and reagents were purchased from
Gibco (Grand Island, New York, USA). Mitomycin c, pigeon
cytochrome c (PCC), and hen egg lysozyme (HEL) were
purchased from Sigma Chemical Co. (St. Louis, Missouri,
USA). Monoclonal antibodies (mAb) against IEk (clone
14.4.4S, American Type Culture Collection, Rockville, Mary-
land, USA) and the murine CD3-e chain (clone 145.2C11
provided by Dr. Jeffrey Bluestone, University of Chicago,
Chicago, Illinois, USA) were obtained by affinity purification of
supernatants over protein A-Sepharose CL-4B columns (Phar-
macia, Piscataway, New Jersey, USA). Murine rIFN-y was a
gift from Genentech (San Francisco, California, USA).
T cell clone proliferation assay
All cultures were performed in RPMI 1640 supplemented
with 10% fetal bovine serum (FBS; HyClone, Logan, Utah,
USA), 50 sM 2-ME, 10 mri HEPES, 1 m Na pyruvate, 0.1 mM
non-essential amino acids, and antibiotics. Two to three x 10"
cloned T cells were cultured in 96-well flat-bottom microtiter
plates (Falcon, Lincoln Park, New Jersey, USA) in 0.2 ml of
medium with one of two types of stimulator cells: 5 x l0
irradiated (1500R) syngeneic splenocytes or 2 x iO to 5 X l0
mitomycin c-treated, IFN-y-stimulated (100 U/ml x 72 hr)
CS3. 1 cells. Varying doses of antigen were used. After three
days of culture, wells were pulsed with 1 jsCi of [3H]TdR (6.7
mCi/mM, New England Nuclear, Boston, Massachusetts, USA)
and harvested six hours later using a PHD cell harvester
(Cambridge Technology Inc., Cambridge, Massachusetts,
USA). Thymidine incorporation was quantitated by liquid scin-
tillation counting. Determinations were performed in triplicate.
Background proliferation (without antigen) was always <1,000
cpm.
IL-2 assay
IL-2 was assayed by measuring the ability of 24-hour culture
supernatants to support the growth of 1 x l0 HT-2 cells, an
IL-2-dependent cell line provided by Dr. Abul Abbas. After 24
hours, cultures were pulsed with 1 pCi of [3H]TdR, harvested
six hours later and thymidine incorporation quantitated as
above. As a positive control, HT-2 cells were also cultured with
serial dilutions of human rIL-2 (gift of Dr. Jack Murphy, Boston
University, Boston, Massachusetts, USA).
Fluorescence cytometry
Subconfluent monolayers of TEC were cultured for 72 hours
in modified Kl medium [1:1 mixture of Dulbecco's modified
Eagle's medium (DMEM) and Ham's F12, containing additives
as described including 25 ng/ml of epidermal growth factor] with
or without IFN-y (100 U/mI). Cells were harvested by
Table 1. Flow cytometric analysis of MHC class II expression by
TEC
TEC Preincubation % I-E expression
Exp. 1 CS3.l(5 x 105/well) medium
100 U/ml IFN-y
2.0
95.6
Exp. 2 CS3.1(5 x 105/well) medium
100 U/ml IFN-y
1.7
68.6
CS3. 1 cells were cultured for 72 hours under the above conditions,
and harvested by trypsinization. IEk expression was analyzed as
described in the Methods.
trypsinization, and resuspended at 5 x i05 to 1 x 106 cells/mI in
PBS with 3% FBS/0.l% NaN3. Cells were analyzed for the
surface expression of B7 using the fluorescein-conjugated anti-
murine B7 mAb 1G1O on a Coulter Epics Flow Cytometer.
Fluorescein-conjugated anti-murine B7 mAb 1G1O on a Coulter
Epics Flow Cytometer. Fluorescein-conjugated IgG2a was used
as a negative control. Staining for IEk was performed by
incubating cells with the mAb 14.4.4S, followed by FITC-
conjugated anti-mouse IgG.
Isolation of peritoneal exudate cells
Peritoneal exudate cells (PEC) were harvested by peritoneal
lavage with 5 ml of HBSS supplemented with antibiotics. The
cells were washed and resuspended in RPM! 1640 supple-
mented with 10% FBS and 100 g/ml of both penicillin and
streptomycin, and 106 cells/mi were plated on 100 mm plastic
petri dishes (Fisher Scientific Co., Pittsburgh, Pennsylvania,
USA). After overnight incubation at 37°C, adherent cells were
washed off and resuspended in RPM! 1640 supplemented as
above prior to co-culture with T cells.
Induction of T cell anergy
A.E7 cells (7 x 105/well) were preincubated in 2.0 ml medium
in 24-well plates with 1 x 106 mitomycin c-treated, IFN-y-
stimulated C53.1, with or without antigen. The T cell clones
were also cultured with 5 x 106 irradiated (lSOOR) syngeneic
splenocytes and Ag or on anti-CD3 mAb-coated wells as
controls. After 24 to 48 hours of culture, T cells were recovered
on Ficoll-Hypaque (Cedarlane Laboratory Ltd., Hornby, On-
tario, Canada) density gradients and rested for 48 to 72 hours
prior to culture for three days in 96-well microtiter plates (2 to
3 x i0 cells/well) with 5 x l0 irradiated syngeneic splenocytes
and antigen or with IL-2 alone. Proliferation and !L-2 produc-
tion were assayed as described above.
Results
The TEC clone CS3. 1 is clearly tubular in origin and was
extensively characterized as previous cell lines have been
described [19]. These cells do not express MHC class I!
molecules constitutively. However, Ia expression on CS3. 1 is
readily induced by IFN-y (Table 1). The level of Ia expression
by CS3.l is higher than previous cell lines from C3H/FeJ mice
(Cl, C1.l) [19]. Expression of MHC class II products is a
feature common to antigen presenting cells such as B lympho-
cytes, macrophages and dendritic cells.
In order to determine the ability of TEC to process and
present antigen, CS3. 1 were cultured with the IAkrestricted,
HEL-specific T cell hybridoma A2.A2 in the presence of
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Fig. 1. TEC stimulate IL-2 production by a T cell hybrid. CS3.1 cells
were harvested after culture in medium alone (-0-) or IFN-y (100 U/nil)
(-U-) for 72 hours. TEC (5 x 104/well) were added to 96-well culture
plates containing the T cell hybridoma A2.A2 (1 x l05/welI) and varying
concentrations of the antigen HEL in a final volume of 0.2 ml. A2.A2
were also cultured with C3H/FeJ splenocytes (—-) and Ag. After 24
hours, 0.05 ml of supernatant was added to the IL-2-dependent cell line
HT-2 (1 x 104/wefl) in a final volume of 0.1 ml. After 24 hours, the wells
were pulsed with [3H] TdR (I pCi/well), and IL-2 production quanti-
tated as [3H] TdR incorporation. The data shown are cpm and repre-
sentative of three separate experiments. SEM for cpm values were
routinely less than 20%.
varying amounts of antigen. Mter 24 hours, supernatants were
assayed for IL-2 using the indicator cell line HT-2. As shown in
Figure 1, TEC treated with IFN-y were able to stimulate IL-2
production by the T cell hybridoma. This response was depen-
dent on the presence of Ag and Ia expression, since untreated
TEC failed to induce IL-2 production. Peak responses to
stimulated TEC, seen at HEL concentrations of 10 pg/m1 were
2.5- to 3-fold lower than those to spleen cells.
T cell hybridomas often do not require costimulatory ligands,
and can be stimulated by Ia molecules on a planar lipid
membrane [201. To further assess the antigen presenting capac-
ity of TEC, CS3. 1 were co-cultured with a normal T cell clone,
A.E7. This clone is CD4 and is of the Thi subtype, prolifer-
ating and secreting IL-2 and IFN-y in response to the c-terminal
fragment (residues 81-104) of pigeon cytochrome c bound to
IEk. In multiple experiments, A.E7 clones proliferated when
cultured with syngeneic spleen cells and antigen, but did not
respond to unstimulated or IFN-y-treated CS3. 1 (Fig. 2).
It has previously been shown that engagement of the T cell
receptor without provision of an appropriate costimulatory
signal results in antigen-specific unresponsiveness, or anergy,
in CD4 T cells of the Thl subtype [15, 16, 21]. Anergic T cells
fail to secrete IL-2 or proliferate when restimulated with
competent APC and Ag. The cells remain viable as manifested
by their proliferative response to IL-2. In order to demonstrate
that TEC could functionally inactivate T cell clones, A.E7 were
cultured with CS3.1 overnight, recovered and rested for two
days in medium alone, and restimulated with either spleen APC
and Ag or IL-2. A representative experiment shown in Figure 3
demonstrates that A.E7 preincubated with stimulated CS3. 1
and Ag no longer proliferated in response to spleen APC and
specific Ag. The cells remained viable as established by their
response to IL-2. This effect was also seen in T cells cultured on
PCC concentration, ig/ml
Fig. 2. TEC fail to stimulate prol:feraion by a normal T cell clone. 5 x
iO mitomycin c-treated CS3.l (-0—) or IFN-y.stimulated CS3.1 (—-),
or5 x l0 1500 rad irradiated C3H/FeJ splenocytes (—) were cultured
with 3 x lO A.E7 cloned T cells and varying amounts of pigeon
cytochrome c (PCC). Cultures were pulsed after 72 hours and harvested
6 hours later. Values are cpm and representative of three experiments.
SEM were always less than 20%.
plate-bound anti-CD3 mAb prior to restimulation. T cell clones
pre-cultured with either spleen APC and Ag, or stimulated
CS3. 1 without antigen were not rendered unresponsive.
Previous experiments have shown that allogeneic spleen cells
can provide the necessary costimulatory signal(s) to prevent T
cell unresponsiveness induced by chemically modified APC
[22]. We postulated that TEC may lack the ability to deliver a
second signal, and thereby functionally inactivate T cells. The
B cell activation marker B7 has been shown to costimulate T
cells by binding to its ligands CD28 and CTLA-4 [23—27]. CS3. 1
did not stain for B7 by flow cytometry regardless of whether or
not the cells had been pre-treated with IFN-y (Fig. 4). To
further define the role of costimulators in anergy induction by
TEC, Thi clones were incubated with stimulated CS3. 1 and Ag.
Allogeneic spleen cells or peritoneal exudate cells (PEC) were
added to the cultures, but failed to restore a T cell proliferative
response (Fig. 5).
Discussion
TEC express multiple molecules which would enable them to
function as immune accessory cells. Notably, they can be
induced to express MHC class II products in vitro and in vivo
[1, 2, 4, 28, 29]. They also secrete a variety of cytokines and
express the surface molecules ICAM-1 and VCAM-1. Using the
transformed TEC clone CS3. 1, we reported that TEC, when
stimulated by IFN-y to express Ia, can process and present
protein antigen to I cell hybridomas. As we have previously
noted, peak proliferative responses to TEC were almost three-
fold lower than those to spleen APC. A number of factors may
contribute to this apparent inefficiency in antigen presentation
by TEC: (i) Ia expression on TEC may be at a lower density
than that on spleen cells; (ii) TEC form a monolayer, and
therefore only a fraction of the cell surface is exposed to the T
cells in culture; and (iii) we used tenfold fewer TEC per well
than spleen cells due to steric constraints. Correcting for these
variables, TEC may in fact be equally efficient at stimulating T
cell hybridomas as spleen APC.
It is known that T cell hybridomas can be readily induced to
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Fig. 3. TEC induce T cell unresponsiveness in
vitro. Symbols are: (A) TEC* + Ag; ()
TEC; (0) anti-CD3; (•) SPL + Ag. A.E7
cloned T cells (7 x 10>) were incubated in 24-
well plates with 1 x 106 mitomycin c-treated,
• IFN-y-stimulated CS3.l (TEC*) in the
presence or absence of pigeon cytochrome c
O (PCC) (100 og/ml), or 5 x 106 1500 rad
irradiated C3H/FeJ splenocytes (SPL) and
PCC. A.E7 were also cultured on anti-CD3 (3
sg/ml) mAb-coated wells. T cells were
recovered after 24 hours, and rested in
medium. After 48 hours, A.E7 cloned T cells
(2 x l04/well) were restimulated in 96-well
plates with 5 x 10> 1500 rad irradiated C3HI
FeJ splenocytes and varying concentrations of
antigen (PCC), or with IL-2 (25 U/ml). After
72 hours, cultures were pulsed (1 sCi/well25 [3H] TdR) and harvested 6 hours later. Values
are cpm and representative of three
IL-2 concentration, U/mi experiments. SEM were less than 20%.
secrete IL-2 in response to MHC class II plus peptide on planar
lipid membranes [20]. T cell clones, on the other hand, require
a costimulatory signal as well as T cell receptor engagement in
order to become activated [16]. Failure to provide this second
signal results in antigen-specific T cell unresponsiveness, or
anergy. We have shown that Ia-bearing TEC, in the presence of
antigen, render the Thi clone A.E7 unresponsive to restimula-
tion with competent APC and antigen. The anergic T cells
remain viable, proliferating in response to IL-2. Furthermore,
stimulated TEC do not express the costimulatory molecule B7.
Based on these results and previous studies examining the
antigen presenting capacity of non-hematopoietic cells, we
hypothesized that TEC may lack the necessary second signal(s)
required to activate T cells. We were surprised to find that
allogeneic APC (spleen cells or macrophages) failed to support
T cell proliferation in response to stimulated TEC and Ag. B7
binds one of two ligands on T cells, CD28 or CTLA-4 [25, 30].
Preliminary experiments show that the mAb to murine CD28 is
also unable to prevent T cell anergy induced by stimulated TEC
(unpublished observations). These studies suggest that the
absence of appropriate costimulatory ligands on TEC does not
completely explain our observations. There exist at least two
systems for inducing T cell anergy in vitro. T cells cultured with
chemically modified APC and antigen are rendered unrespon-
sive [15]; this state can be prevented by providing the appro-
priate second signal(s) on allogeneic spleen cells [22]. T cells
cultured on anti-CD3 mAb-coated wells are also inactivated,
but this anergic state is less costimulator-dependent, that is,
allogeneic APC will not completely prevent anti-CD3 mAb-
induced anergy [31]. Therefore, it could be that stimulated TEC
provide the same, or a similar, signal as anti-CD3 mAb,
rendering T cells unresponsive. The inhibitory signal provided
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Fig. 5. Allogeneic accessory cells fail to restore T cell proliferation in
response to TEC. A.E7 cells (3 x 104/well) were cultured with mitomy-
cm c-treated IFN-stimulated CS3. 1 (TEC*) (5 x l04/well) with or
without 1500 rad irradiated BALB/c splenocytes (aI10SPL) (5 x l0-5 )<
105/well), with or without mitomycin c-treated BALB/c peritoneal
exudate cells (a1I0PEC) (4 x l0-4 x 104/well) and varying amounts of
antigen (PCC). A.E7 T cells were also cultured with 5 x l0 1500 rad
irradiated C3H/FeJ splenocytes (SPL) and antigen. Proliferation was
measured after 72 hours by [3H] TdR incorporation. Symbols in A are:
() TEC*; (A) TEC* + alloSPL (5 x 10E4); (A) TEC* + aIIoSPL (5 x
10E5); (•) SPL. Symbols in B are: (•) TEC*; (A) TEC* + aIIoPEC (4
x lOE3); (A) TEC* + alloPEC (4 x 10E4); (•) SPL.
by TEC may result directly from engagement of the TCR-CD3
complex, or could be secondary to TEC secretion of cytokines
such as transforming growth factor /3.
The tubular epithelial cell line MCT, described by Haverty
and colleagues, has previously been shown to stimulate the
proliferation of tubular antigen (3M-l)-specific, class II MHC-
restricted T cells in vitro, despite low-level Ia expression [32].
Therefore, cultured TEC may either stimulate or neutralize T
cell clones, depending on the nature of the costimulatory
signal(s) provided. A recent report by Hagerty and Allen
demonstrates that TEC are capable of processing foreign and
self antigen in vivo as manifested by their ability to stimulate T
cell hybridomas in vitro [33]. However, there is little evidence
that TEC can activate T cells in vivo. Further experiments are
required to determine whether or not TEC can be induced to
express the appropriate costimulatory molecule(s) in vivo. Our
results indicate that, under certain conditions, TEC can func-
tionally inactivate CD4 T cells. Therefore, TEC stimulated to
express certain immune accessory molecules may function to
regulate autoimmune processes within the kidney by paralyzing
self-reactive T cell clones.
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